- Home
- ATOS vs RBKB Comparison
ATOS vs RBKB Comparison
Compare ATOS & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- RBKB
- Stock Information
- Founded
- ATOS 2009
- RBKB 1860
- Country
- ATOS United States
- RBKB United States
- Employees
- ATOS N/A
- RBKB N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- RBKB Banks
- Sector
- ATOS Health Care
- RBKB Finance
- Exchange
- ATOS Nasdaq
- RBKB Nasdaq
- Market Cap
- ATOS 107.2M
- RBKB 111.3M
- IPO Year
- ATOS 2012
- RBKB 2019
- Fundamental
- Price
- ATOS $0.82
- RBKB $12.40
- Analyst Decision
- ATOS Strong Buy
- RBKB
- Analyst Count
- ATOS 3
- RBKB 0
- Target Price
- ATOS $6.17
- RBKB N/A
- AVG Volume (30 Days)
- ATOS 1.4M
- RBKB 12.3K
- Earning Date
- ATOS 08-15-2025
- RBKB 07-24-2025
- Dividend Yield
- ATOS N/A
- RBKB N/A
- EPS Growth
- ATOS N/A
- RBKB N/A
- EPS
- ATOS N/A
- RBKB N/A
- Revenue
- ATOS N/A
- RBKB $31,018,000.00
- Revenue This Year
- ATOS N/A
- RBKB N/A
- Revenue Next Year
- ATOS N/A
- RBKB N/A
- P/E Ratio
- ATOS N/A
- RBKB N/A
- Revenue Growth
- ATOS N/A
- RBKB N/A
- 52 Week Low
- ATOS $0.55
- RBKB $7.30
- 52 Week High
- ATOS $1.66
- RBKB $13.06
- Technical
- Relative Strength Index (RSI)
- ATOS 44.93
- RBKB 51.22
- Support Level
- ATOS $0.84
- RBKB $12.69
- Resistance Level
- ATOS $0.98
- RBKB $12.64
- Average True Range (ATR)
- ATOS 0.05
- RBKB 0.35
- MACD
- ATOS -0.01
- RBKB -0.01
- Stochastic Oscillator
- ATOS 7.65
- RBKB 53.19
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one- to four-family residential real estate loans, and to purchase investment securities.